Psychosocial support for caregivers of patients with acute leukemia
Pilot Study of a Novel Psychotherapeutic Intervention for Caregivers of Patients With Acute Leukemia: Emotion and Symptom-focused Engagement for Caregivers (EASE-CG)
This study is testing a new support program for caregivers of patients with acute leukemia to see if it helps them feel less stressed and more at ease.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Health Network, Toronto Academic / other |
| Locations | 2 sites (Toronto, Ontario and 1 other locations) |
| Trial ID | NCT05236296 on ClinicalTrials.gov |
What this trial studies
This pilot study evaluates the feasibility and acceptability of a psychosocial intervention called Emotion and Symptom-focused Engagement for Caregivers (EASE-CG) aimed at reducing traumatic stress and psychological distress in primary caregivers of patients newly diagnosed with acute leukemia. The intervention is adapted from a previous program designed for patients and focuses on enhancing the well-being of caregivers. Participants will undergo quantitative assessments at multiple time points and may also participate in semi-structured interviews to provide qualitative insights into their experiences.
Who should consider this trial
Good fit: Ideal candidates are primary or co-primary caregivers of patients newly diagnosed with acute leukemia within three months of hospital admission.
Not a fit: Patients who are not caregivers or those who do not meet the inclusion criteria will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the mental health and well-being of caregivers, leading to better support for patients with acute leukemia.
How similar studies have performed: Previous studies have shown success with similar psychosocial interventions for patients with acute leukemia, indicating potential for caregiver-focused approaches.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-identified primary caregiver (i.e., person assuming the majority of care activities) or co-primary caregiver (i.e., assuming at least 40% of care activities alongside another co-primary caregiver) of an adult or pediatric patient who is newly diagnosed with acute leukemia within 3 months of admission to the Princess Margaret Cancer Centre or the Hospital for Sick Children * Age ≥18 years * Fluency in English Exclusion Criteria: none
Where this trial is running
Toronto, Ontario and 1 other locations
- The Hospital for Sick Children — Toronto, Ontario, Canada (Recruiting)
- Princess Margaret Cancer Centre — Toronto, Ontario, Canada (Recruiting)
Study contacts
- Principal investigator: Gary Rodin, MD FRCPC — University Health Network, Toronto
- Study coordinator: Ally Yu
- Email: ally.yu@uhnresearch.ca
- Phone: 416-813-7654
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.